Standardization of poliovirus neutralizing antibody tests is necessary due to high inter-laboratory variability, and a specific protocol using medium to low virus dose with overnight incubation at 36 C optimizes sensitivity and reproducibility.
Answers are grounded in this paper and cite their sources.
Inter-laboratory variability may affect clinical interpretation of poliovirus titers; standardized protocols require prospective validation before routine use.
Recently the Forum for Advancement of Immunization Research sponsored a Collaborative Study on Poliovirus Antibody Titration. Twenty laboratories from 12 countries participated. There were considerable differences in detail of test performance and test results among laboratories. The sensitivity of the tests varied over a 10-fold range (geometric mean titer from 21 to 288). The average coefficient of variation ranged from 4.5% to 13.5%. Tests performed at the Food and Drug Administration indicated that Hep-2 cells were more suitable than Vero cells for poliovirus titration by cytopathic effect end point or plaque assay. However, the cell lines were equally suitable for polio antibody titration by neutralization of cytopathic effect. A high degree of sensitivity and optimal reproducibility of antibody assay were observed in tests utilizing a medium to low dose of virus and serum-virus incubation overnight at 36 C. On the basis of current experience, a protocol is proposed for a test that provides high sensitivity and reproducibility and is practical for large-scale determinations of poliovirus antibody.
No takes yet. Share an insight, caveat, or question.
Albrecht et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: